Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magdalena Eriksson

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Virchows Archiv : an International Journal of Pathology|May 27, 2008
Three German fibrinogen Aalpha-chain amyloidosis patients with the p.Glu526Val mutationMagdalena Eriksson, Stefan Schönland, Raoul Bergner, et al.
Acta Neurologica Scandinavica|November 7, 2019
Activities of daily living in Parkinson's disease: Time/gender perspectiveMaria Sperens, Dejan Georgiev, Magdalena Eriksson Domellöf, et al.
Frontiers in Immunology|July 25, 2013
The C-Type Lectin Receptor SIGNR3 Binds to Fungi Present in Commensal Microbiota and Influences Immune Regulation in Experimental ColitisMagdalena Eriksson, Timo Johannssen, Dorthe von Smolinski, et al.
BMC Neurology|September 7, 2020
Evaluating a frontostriatal working-memory updating-training paradigm in Parkinson's disease: the iPARK trial, a double-blinded randomized controlled trialMagdalena Eriksson Domellöf, Lois Walton, Carl-Johan Boraxbekk, et al.
Chembiochem : a European Journal of Chemical Biology|March 12, 2014
Biological evaluation of multivalent lewis X-MGL-1 interactionsMagdalena Eriksson, Sonia Serna, Maha Maglinao, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 26, 2013
A platform to screen for C-type lectin receptor-binding carbohydrates and their potential for cell-specific targeting and immune modulationMaha Maglinao, Magdalena Eriksson, Mark K Schlegel, et al.
Journal of the Neurological Sciences|October 10, 2017
PITX3 genotype and risk of dementia in Parkinson's disease: A population-based studyDavid Bäckström, Magdalena Eriksson Domellöf, Gabriel Granåsen, et al.
Plos One|July 29, 2014
Role of the C-type lectin receptors MCL and DCIR in experimental colitisJulia Hütter, Magdalena Eriksson, Timo Johannssen, et al.
Virchows Archiv : an International Journal of Pathology|April 9, 2010
Amyloid in endomyocardial biopsiesBarbara Kieninger, Magdalena Eriksson, Reinhard Kandolf, et al.
Brain Communications|March 30, 2022
Prediction and early biomarkers of cognitive decline in Parkinson disease and atypical parkinsonism: a population-based studyDavid Bäckström, Gabriel Granåsen, Susanna Jakobson Mo, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Virchows Archiv : an International Journal of Pathology|May 27, 2008
Three German fibrinogen Aalpha-chain amyloidosis patients with the p.Glu526Val mutationMagdalena Eriksson, Stefan Schönland, Raoul Bergner, et al.
Acta Neurologica Scandinavica|November 7, 2019
Activities of daily living in Parkinson's disease: Time/gender perspectiveMaria Sperens, Dejan Georgiev, Magdalena Eriksson Domellöf, et al.
Frontiers in Immunology|July 25, 2013
The C-Type Lectin Receptor SIGNR3 Binds to Fungi Present in Commensal Microbiota and Influences Immune Regulation in Experimental ColitisMagdalena Eriksson, Timo Johannssen, Dorthe von Smolinski, et al.
BMC Neurology|September 7, 2020
Evaluating a frontostriatal working-memory updating-training paradigm in Parkinson's disease: the iPARK trial, a double-blinded randomized controlled trialMagdalena Eriksson Domellöf, Lois Walton, Carl-Johan Boraxbekk, et al.
Chembiochem : a European Journal of Chemical Biology|March 12, 2014
Biological evaluation of multivalent lewis X-MGL-1 interactionsMagdalena Eriksson, Sonia Serna, Maha Maglinao, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 26, 2013
A platform to screen for C-type lectin receptor-binding carbohydrates and their potential for cell-specific targeting and immune modulationMaha Maglinao, Magdalena Eriksson, Mark K Schlegel, et al.
Journal of the Neurological Sciences|October 10, 2017
PITX3 genotype and risk of dementia in Parkinson's disease: A population-based studyDavid Bäckström, Magdalena Eriksson Domellöf, Gabriel Granåsen, et al.
Plos One|July 29, 2014
Role of the C-type lectin receptors MCL and DCIR in experimental colitisJulia Hütter, Magdalena Eriksson, Timo Johannssen, et al.
Virchows Archiv : an International Journal of Pathology|April 9, 2010
Amyloid in endomyocardial biopsiesBarbara Kieninger, Magdalena Eriksson, Reinhard Kandolf, et al.
Brain Communications|March 30, 2022
Prediction and early biomarkers of cognitive decline in Parkinson disease and atypical parkinsonism: a population-based studyDavid Bäckström, Gabriel Granåsen, Susanna Jakobson Mo, et al.
Pageof 3